Target intelligence / Profile preview

50S ribosomal subunit (50S subunit)

Target
50S subunit
Molecular classification
Ribonucleoprotein complex, Ribosome
01

Overview

The 50S ribosomal subunit is the larger component of the 70S ribosome found in bacteria and the apicoplast organelle of apicomplexan parasites such as Plasmodium falciparum (Dahl & Rosenthal, 2007, Antimicrobial Agents and Chemotherapy). It is a complex ribonucleoprotein assembly responsible for the peptidyl transferase activity that catalyzes peptide bond formation and contains the exit tunnel through which the nascent polypeptide chain emerges (NCBI Bookshelf, 'The Ribosome'). Because the apicoplast is an essential organelle of endosymbiotic bacterial origin, its translation machinery is highly conserved with bacterial systems and distinct from the human 80S cytosolic ribosome. This structural divergence allows for the selective targeting of pathogens by several classes of antimicrobial agents, including macrolides, lincosamides, and oxazolidinones (StatPearls, 'Macrolides'). In malaria treatment, drugs targeting the apicoplast 50S subunit often exhibit a 'delayed death' effect, where the parasite's progeny are unable to survive due to the loss of apicoplast function in the second generation (Botté et al., 2012, Genes & Development). However, the structural similarity between the 50S subunit and human mitochondrial ribosomes can lead to off-target effects and clinical toxicity, such as myelosuppression or lactic acidosis, during prolonged treatment (Wilson, 2014).

Other names
Large ribosomal subunitBacterial 50S ribosomeApicoplast 50S ribosomeProkaryotic 50S subunit70S ribosome large subunit
02

Mechanism of action

Inhibition of protein synthesis by binding to the 50S ribosomal subunit, which blocks the peptidyl transferase center (PTC) or the ribosomal exit tunnel, thereby preventing peptide bond formation or the translocation of the nascent peptide chain (Wilson, 2014, Nature Reviews Microbiology).

03

Biological functions

Protein synthesisTranslationPeptidyl transferase activityPolypeptide chain elongationRibozyme activity
04

Disease associations

Bacterial infectionMalariaApicomplexan infectionToxoplasmosis
05

Safety considerations

Mitochondrial toxicity due to structural similarity with human mitochondrial ribosomesAntibiotic resistance (e.g., MRSA, VRE)Gastrointestinal dysbiosis and Clostridioides difficile infectionMyelosuppression (associated with long-term oxazolidinone use)Delayed death phenotype in Plasmodium (therapeutic challenge)
06

Interacting drugs

Azithromycin

11 more in the full profile.

07

Biomarkers

23S rRNA mutationsL4 ribosomal protein mutationsL22 ribosomal protein mutationsErm-mediated dimethylation of A2058Bacterial loadParasitemia levels

Beyond the preview

Go deeper on 50S ribosomal subunit (50S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 50S ribosomal subunit (50S subunit).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call